The aims of the Clinical Trials Standing Committee are to:
- provide investigators with authoritative guidelines for randomised controlled trials (RCTs) in the major headache disorders, especially migraine, tension-type headache and cluster headache
- draw on the experience of senior clinical investigators and those working in the field in the pharmaceutical industry to develop, elaborate, and from time to time update these guidelines
- advise medicines regulatory agencies who may be producing notes for guidance in the clinical development of drugs, devices or other treatments for use against headache disorders
- otherwise support and promote evidence-based headache medicine.
To access all published Clinical Trial guidelines please visit the Guidelines page.
- Hans-Christoph Diener
- Cristina Tassorelli
- Messoud Ashina
- Peter Goadsby
- Elizabeth Leroux
- Richard Lipton
- Patricia Pozo Rosich
- Shuu-Jiun Wang
- Marie Deen Christensen
- Thomas van den Hoek
Мероприятия и новости
The Clinical Trials Standing Committee has produced methodological guidelines on the design, conduct and analysis of controlled trials of drugs for treatment or prevention of migraine, tension-type headache, cluster headache, chronic migraine and adverse events.
The Committee is also currently involved in the development of other IHS Guidelines, such as Health Technology Assessment and evidence-based grade tables.